[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @biospace BioSpace BioSpace posts on X about flu, $4552t, specialized, regulatory the most. They currently have XXXXXX followers and 1053 posts still getting attention that total XXXXX engagements in the last XX hours. ### Engagements: XXXXX [#](/creator/twitter::21793154/interactions)  - X Week XXXXX -XX% - X Month XXXXXX +93% - X Months XXXXXX +12% - X Year XXXXXXX +31% ### Mentions: XX [#](/creator/twitter::21793154/posts_active)  ### Followers: XXXXXX [#](/creator/twitter::21793154/followers)  - X Week XXXXXX +0.08% - X Month XXXXXX +0.34% - X Months XXXXXX +1.10% - X Year XXXXXX +1.50% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::21793154/influencer_rank)  ### Social Influence [#](/creator/twitter::21793154/influence) --- **Social category influence** [finance](/list/finance) [stocks](/list/stocks) **Social topic influence** [flu](/topic/flu), [$4552t](/topic/$4552t), [specialized](/topic/specialized), [regulatory](/topic/regulatory), [acquisition](/topic/acquisition), [tariffs](/topic/tariffs), [drugs](/topic/drugs), [money](/topic/money), [$4768t](/topic/$4768t), [$4578t](/topic/$4578t) **Top assets mentioned** [Gilead Sciences, Inc. (GILD)](/topic/gilead-sciences) ### Top Social Posts [#](/creator/twitter::21793154/posts) --- Top posts by engagements in the last XX hours "Earlier this summer the FDA asked @moderna_tx for more efficacy data on its flu vaccine before it could review an mRNA-based combination shot that targets both influenza and COVID-19. Now the entire vaccine sector is sizing up a new regulatory world companies next steps uncertain. #FDA #vaccines #flu #biospace"  [@biospace](/creator/x/biospace) on [X](/post/tweet/1947282603859411395) 2025-07-21 13:08:46 UTC 25.1K followers, XXX engagements "The deal gives @AstraZeneca's rare disease unit Alexion access to specialized capsids developed by the Japanese biotech JCR Pharmaceuticals for use in up to five of Alexions gene therapies. #genetherapy #biospace"  [@biospace](/creator/x/biospace) on [X](/post/tweet/1942993899972067599) 2025-07-09 17:06:59 UTC 25.1K followers, XXX engagements "The safety update for Vyvgart rattled argenxs shares on Monday a reaction that analysts at William Blair said was overdone. #regulatory #FDA #biospace"  [@biospace](/creator/x/biospace) on [X](/post/tweet/1940426987748601919) 2025-07-02 15:06:59 UTC 25.1K followers, XXX engagements "Analysts believe that @GileadSciences's new PrEP drug Yeztugo could reach peak sales of $XXX billion. Not if @GSK has anything to say about it. #HIV #pharma #biospace"  [@biospace](/creator/x/biospace) on [X](/post/tweet/1940410124150980904) 2025-07-02 13:59:59 UTC 25.1K followers, XXX engagements "After consistently failing to meet investor expectations @novonordisk touted a safety profile for CagriSema in line with the GLP1-RA class while reporting mid-stage data for its GLP1- and amylin-targeting drug amycretin that raised dosing questions. #glp1 #obesity #biospace"  [@biospace](/creator/x/biospace) on [X](/post/tweet/1937171284774777046) 2025-06-23 15:29:59 UTC 25.1K followers, XXX engagements "Shanghai-based LaNova Medicineswhich has captured the attention of some of the biggest Western pharmaswill be folded into fellow Chinese company Sino Biopharmaceutical in a deal worth up to $XXX million. #pharma #acquisition #biospace"  [@biospace](/creator/x/biospace) on [X](/post/tweet/1945506204186292732) 2025-07-16 15:29:59 UTC 25.1K followers, XXX engagements "The money will focus on a manufacturing plant in Virginia that will make the companys weight management and metabolic drugs like the hypertension drug baxdrostat and oral GLP-1 therapies. #GLP1 #tariffs #manufacturing #biospace"  [@biospace](/creator/x/biospace) on [X](/post/tweet/1947680530700378295) 2025-07-22 15:29:59 UTC 25.1K followers, XXX engagements "Otsuka and Lundbecks data are insufficient to establish significant efficacy of Rexulti plus sertraline in PTSD according to the FDAs outside experts. #PTSD #FDA #biospace"  [@biospace](/creator/x/biospace) on [X](/post/tweet/1947318144072139077) 2025-07-21 15:29:59 UTC 25.1K followers, XXX engagements "The Global Fund to Fight AIDS Tuberculosis and Malaria will work with @GileadSciences and other private backers to ensure the HIV preventive Yeztugo approved last month by the FDA is available in low- and middle-income countries concurrent with high-income nations. #HIV #FDA #biospace"  [@biospace](/creator/x/biospace) on [X](/post/tweet/1943301701122859461) 2025-07-10 13:30:05 UTC 25.1K followers, XXX engagements "Following the death of two teenage patients with Duchenne muscular dystrophy following Elevidys treatment Sarepta Therapeutics adds a black box warning to the gene therapy for acute liver injury and failure and parts with more than a third of employees. #layoffs #genetherapy #pharma #biospace"  [@biospace](/creator/x/biospace) on [X](/post/tweet/1945829772426182836) 2025-07-17 12:55:44 UTC 25.1K followers, XXX engagements "Sarepta Therapeutics stock has dropped precipitously as questions swirl around the safety of its gene therapies. Meanwhile the Duchenne patient community fears losing access to Elevidys while the regulator considers more drastic action. #FDA #biospace"  [@biospace](/creator/x/biospace) on [X](/post/tweet/1947720293906031078) 2025-07-22 18:07:59 UTC 25.1K followers, XXX engagements "BMO Capital Markets pointed to FDA leadership and CBER Director Vinay Prasad in particular as potential factors in the agencys decision to issue a complete response letter for Replimmunes viral treatment RP1 for advanced melanomas. Shares of the company tumbled XX% on Tuesday. #FDA #CBER #biospace"  [@biospace](/creator/x/biospace) on [X](/post/tweet/1947705446082531613) 2025-07-22 17:08:59 UTC 25.1K followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@biospace BioSpace
BioSpace posts on X about flu, $4552t, specialized, regulatory the most. They currently have XXXXXX followers and 1053 posts still getting attention that total XXXXX engagements in the last XX hours.
Engagements: XXXXX #
- X Week XXXXX -XX%
- X Month XXXXXX +93%
- X Months XXXXXX +12%
- X Year XXXXXXX +31%
Mentions: XX #
Followers: XXXXXX #
- X Week XXXXXX +0.08%
- X Month XXXXXX +0.34%
- X Months XXXXXX +1.10%
- X Year XXXXXX +1.50%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence finance stocks
Social topic influence flu, $4552t, specialized, regulatory, acquisition, tariffs, drugs, money, $4768t, $4578t
Top assets mentioned Gilead Sciences, Inc. (GILD)
Top Social Posts #
Top posts by engagements in the last XX hours
"Earlier this summer the FDA asked @moderna_tx for more efficacy data on its flu vaccine before it could review an mRNA-based combination shot that targets both influenza and COVID-19. Now the entire vaccine sector is sizing up a new regulatory world companies next steps uncertain. #FDA #vaccines #flu #biospace"
@biospace on X 2025-07-21 13:08:46 UTC 25.1K followers, XXX engagements
"The deal gives @AstraZeneca's rare disease unit Alexion access to specialized capsids developed by the Japanese biotech JCR Pharmaceuticals for use in up to five of Alexions gene therapies. #genetherapy #biospace" @biospace on X 2025-07-09 17:06:59 UTC 25.1K followers, XXX engagements
"The safety update for Vyvgart rattled argenxs shares on Monday a reaction that analysts at William Blair said was overdone. #regulatory #FDA #biospace" @biospace on X 2025-07-02 15:06:59 UTC 25.1K followers, XXX engagements
"Analysts believe that @GileadSciences's new PrEP drug Yeztugo could reach peak sales of $XXX billion. Not if @GSK has anything to say about it. #HIV #pharma #biospace" @biospace on X 2025-07-02 13:59:59 UTC 25.1K followers, XXX engagements
"After consistently failing to meet investor expectations @novonordisk touted a safety profile for CagriSema in line with the GLP1-RA class while reporting mid-stage data for its GLP1- and amylin-targeting drug amycretin that raised dosing questions. #glp1 #obesity #biospace" @biospace on X 2025-06-23 15:29:59 UTC 25.1K followers, XXX engagements
"Shanghai-based LaNova Medicineswhich has captured the attention of some of the biggest Western pharmaswill be folded into fellow Chinese company Sino Biopharmaceutical in a deal worth up to $XXX million. #pharma #acquisition #biospace" @biospace on X 2025-07-16 15:29:59 UTC 25.1K followers, XXX engagements
"The money will focus on a manufacturing plant in Virginia that will make the companys weight management and metabolic drugs like the hypertension drug baxdrostat and oral GLP-1 therapies. #GLP1 #tariffs #manufacturing #biospace" @biospace on X 2025-07-22 15:29:59 UTC 25.1K followers, XXX engagements
"Otsuka and Lundbecks data are insufficient to establish significant efficacy of Rexulti plus sertraline in PTSD according to the FDAs outside experts. #PTSD #FDA #biospace" @biospace on X 2025-07-21 15:29:59 UTC 25.1K followers, XXX engagements
"The Global Fund to Fight AIDS Tuberculosis and Malaria will work with @GileadSciences and other private backers to ensure the HIV preventive Yeztugo approved last month by the FDA is available in low- and middle-income countries concurrent with high-income nations. #HIV #FDA #biospace" @biospace on X 2025-07-10 13:30:05 UTC 25.1K followers, XXX engagements
"Following the death of two teenage patients with Duchenne muscular dystrophy following Elevidys treatment Sarepta Therapeutics adds a black box warning to the gene therapy for acute liver injury and failure and parts with more than a third of employees. #layoffs #genetherapy #pharma #biospace" @biospace on X 2025-07-17 12:55:44 UTC 25.1K followers, XXX engagements
"Sarepta Therapeutics stock has dropped precipitously as questions swirl around the safety of its gene therapies. Meanwhile the Duchenne patient community fears losing access to Elevidys while the regulator considers more drastic action. #FDA #biospace" @biospace on X 2025-07-22 18:07:59 UTC 25.1K followers, XXX engagements
"BMO Capital Markets pointed to FDA leadership and CBER Director Vinay Prasad in particular as potential factors in the agencys decision to issue a complete response letter for Replimmunes viral treatment RP1 for advanced melanomas. Shares of the company tumbled XX% on Tuesday. #FDA #CBER #biospace" @biospace on X 2025-07-22 17:08:59 UTC 25.1K followers, XXX engagements